No Data
Allogene Therapeutics To Present Phase 1 Data On ALLO-316 For Advanced CD70 Positive Renal Cell Carcinoma At IKCS And SITC Meetings; FDA Grants RMAT Designation For Potential Single-Infusion AlloCAR T Treatment
Candel Therapeutics To Present Preclinical Results For CAN-3110 In Melanoma At SITC Annual Meeting
China Shenhua Energy Reports Q3 Results
The net profit of the top three coal giants declined overall in the first three quarters, with the leader Shenhua seeing a double increase in net profit in the third quarter compared to the previous quarter. | Interpretations
①Affected by the downward trend of coal prices, the performance of coal listed companies in the first three quarters generally declined, but with differentiated performance in Q3; ②Regarding the future trend of coal prices, the industry generally believes that there is hope for a recovery after hitting the bottom, but the magnitude of the increase is limited.
Xilio Therapeutics To Present Initial Phase 1C Dose Escalation Data For XTX101 In Combination With Atezolizumab In Late-Breaker Poster At SITC 39th Annual Meeting
IMUNON To Present Phase 2 Data Of IMNN-001 At SITC 39th Annual Meeting